AG
Asthika Goonewardene Truist Securities Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
19
Avg Return
Past Year
Past Year
20%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
83.3%
Neutral
16.7%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Hold
Downgraded
| $120 |
5%
upside
| 1 | -15% |
–
| 24 Feb ‘26 14 days ago |
|
|
|
Buy
Initiated
| $40 |
57%
upside
| 1 | -1.5% |
0
%
| 17 Dec ‘25 2 months ago |
|
|
|
Buy
Initiated
| $43 |
70%
upside
| 1 | +18% |
0
%
| 25 Nov ‘25 3 months ago |
|
|
|
Hold
Downgraded
| $30.75 | – | 3 | +8.4% |
0
%
| 13 Nov ‘25 3 months ago |
|
|
|
Buy
Reiterated
| $48 |
72%
upside
| 3 | +10% |
0
%
| 7 Nov ‘25 4 months ago |
|
|
|
Buy
Reiterated
| $145 |
2%
downside
| 2 | +16% |
0
%
| 3 Nov ‘25 4 months ago |
|
|
|
Buy
Reiterated
| $39 |
59%
upside
| 1 | +69% |
0
%
| 7 Oct ‘25 5 months ago |
|
|
|
Hold
Downgraded
| $97 | – | 1 | – |
–
| 29 Sep ‘25 5 months ago |
|
|
|
Buy
Initiated
| $100 |
611%
upside
| 1 | -41% |
0
%
| 10 Sep ‘25 6 months ago |
|
|
|
Buy
Initiated
| $99 |
0%
upside
| 1 | +154% |
0
%
| 5 Sep ‘25 6 months ago |
|
|
|
Buy
Maintained
| $49 |
19%
upside
| 3 | +1.1% |
0
%
| 29 Jul ‘25 7 months ago |
|
|
|
Hold
Maintained
| $1 | – | 1 | – |
–
| 11 Jun ‘25 9 months ago |
|
|
|
Buy
Reiterated
| $155 |
85%
upside
| 2 | -9.2% |
0
%
| 3 Jun ‘25 9 months ago |
|
|
|
Buy
Maintained
| $71 |
263%
upside
| 1 | -37% |
0
%
| 14 May ‘25 10 months ago |
|
|
|
Buy
Maintained
| $10 |
269%
upside
| 1 | +140% |
0
%
| 14 May ‘25 10 months ago |
|
|
|
Buy
Maintained
| $10 |
525%
upside
| 1 | +2.6% |
0
%
| 1 Apr ‘25 11 months ago |
|